US Patent 8188261 Stabilized immune modulatory RNA (SIMRA) compounds
Patent 8188261 was granted and assigned to Idera Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+345 characters)
Article
Patent abstract
The invention relates to the therapeutic use of novel stabilized oligoribonucleotides as immune modulatory agents for immune therapy applications. Specifically, the invention provides novel RNA-based oligoribonucleotides with improved nuclease and RNase stability and that have immune modulatory activity through TLR7 and/or TLR8.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Daqing Wang0
Ekambar Kandimalla0
Lakshmi Bhagat0
Sudhir Agrawal0
Tao Lan0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08188261 Stabilized immune modulatory RNA (SIMRA) compounds US Patent 8188261 Stabilized immune modulatory RNA (SIMRA) compounds
Infobox
Patent Number
08188261
Patent Number
8188261
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08188261 Stabilized immune modulatory RNA (SIMRA) compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08188261
Date of patent
May 29, 2012
Patent application number
12168641
Date Filed
July 7, 2008
Patent primary examiner
Find more entities like US Patent 8188261 Stabilized immune modulatory RNA (SIMRA) compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
